INTRODUCTION 1
The filamentous fungus Aspergillus fumigatus is the primary cause of invasive aspergillosis, an 2 often fatal condition affecting people with a weakened immune system. Along with the 3 immunocompromised population, the incidence of invasive aspergillosis is constantly growing 4 but therapy remains problematic. The sterol binding polyene amphotericin B and ergosterol 5 biosynthesis inhibitor itraconazole have long been the drugs of choice for treatment of this 6 infection. But because of their higher efficacy and lower toxicity, new triazoles such as 7 voriconazole or posaconazole are supplanting these drugs (28, 33) . Additionally, a novel class of 8 antifungal agents called the echinocandins provides further options for treatment. These 9 compounds inhibit the synthesis of β1,3-glucan, a major cell wall component with resultant 10 osmotic instability and lysis (12). Their minimal toxicity and synergistic activity with 11 voriconazole and amphotericin B make them particularly attractive for combination therapy 12 although clinical validation is still awaited (35, 33) . Despite these advances in therapy, invasive 13 aspergillosis is often associated with significant morbidity and mortality emphasizing the need 14 for novel therapeutic strategies based on the fundamental knowledge of A. fumigatus 15 pathogenesis. 16 The development of echinocandins illustrates the viability of targeting enzymes involved in cell 17 wall biosynthesis and encourages the development of chitin synthesis inhibitors. Like glucan and 18 chitin, galactomannan is an abundant component of A. fumigatus cell wall (4) . This 19 polysaccharide composed of a linear mannan core branched with short β1,5-linked 20 galactofuranose (Galf) chains (22) is covalently bound to the cell wall β1,3-glucan, anchored to 21 the lipid membrane by a glycosylphosphatidylinositol (GPI), or released in the environment 22 during tissue invasion or growth in culture (3, 9, 14) . Besides being an abundant component of the 23 extracellular matrix, secreted galactomannans are used for serological diagnostic of invasive 24
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at UNIVERSITEIT GENT/UZGENT on June 18, 2008 ec.asm.org Downloaded from construct, 5' and 3' flanking regions were extended to 5 kb by replacement with re-cloned PCR 1 fragments (primer pairs PS28/PS1 and PS3/PS31) to obtain the final pglfA* construct. 2 The p∆glfA and pglfA* plasmids were linearised (KpnI/SacII) before polyethylene glycol-3 mediated fusion of protoplasts as described in (37) . Transformants were grown on AMM plates 4 containing 1.2 M sorbitol as osmotic stabiliser under appropriate selection conditions and singled 5 out twice before further analysis. Accurate gene deletion and reconstitution were confirmed by 6 southern hybridisation. Southern probes were amplified from genomic DNA using primer pairs 7 PS66A/PS67A, PS68A/PS69A and PS20/PS21. All primer sequences are provided in Table 1 . ground in liquid nitrogen with a mortar and pestle were disrupted by sonication in 6 mL of 5 CHCl 3 /MeOH 1:1. After addition of 3 mL CHCl 3 (to obtain a CHCl 3 /MeOH ratio of 2:1), GIPCs 6 were extracted at room temperature for at least 15 min on a rotating shaker. 3 mL MeOH were 7 then added to lower the density and the mixture centrifuged for 10 min at 2000 g to remove 8 insoluble material. Chloroform and H 2 O were then added to the supernatant to obtain a biphasic 9 system with an 8/4/3 ratio of CHCl 3 /MeOH/H 2 O. After centrifugation for 10 min at 2000 g, 10
GIPCs contained in the upper phase were collected and applied to a C18/SepPak cartridge 11 (Waters, Eschborn, Germany) pre-equilibrated with 5 Survival was monitored for 13 days after infection and moribund animals were sacrificed. 7
Coincidence of severely reduced mobility, low body temperature and breathing problems was 8 defined as moribundity criterion. Statistical analysis of survival data was carried out using the 9 logrank test implemented in Prism 4 (GraphPad Software, San Diego, CA, USA). For 10 quantification experiments, groups of three to five animals were killed two, four and six days 11 after infection and lungs were removed for further analysis. according to (7) . Immediately after removal, mouse lungs were transferred to a 2 mL screw-cap 24 containing N = 300 to 300,000 molecules (calculated from M w and DNA concentration 2 determined by OD 260 ) of a plasmid bearing the cloned A. fumigatus 18S rDNA gene were plotted 3 against N to generate a calibration curve which was then used to assign a rDNA copy number to 4 a given sample C T,norm value. Conidial equivalents were calculated from gene copy numbers by 5 means of uninfected tissue samples that were spiked with defined numbers of conidia before 6 tissue homogenisation (7) . Samples, controls and standards were analyzed in triplicates. 7
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RESULTS 1
Deletion and reconstitution of the glfA gene in A. fumigatus. To begin investigating the role 2 of Galf in Aspergillus fumigatus biology, we deleted the gene encoding UGM (GenBank locus 3 tag AJ871145) and named it glfA following the recommendations for gene naming in 4
Aspergillus. To do this, we generated a deletion plasmid containing the regions flanking the glfA 5 coding sequence separated by the bifunctional selection cassette phleo/tk that confers both 6 resistance to phleomycin and sensitivity to 5-fluoro-2'-deoxyuridine (FUDR) (18) . This 7 construct was used to transform protoplasts of A. fumigatus clinical strain D141 which served as 8 wild type (wt) and phleomycin resistant transformants were analyzed by Southern Blot using 9 several digoxigenin-labeled probes (Fig. 1) . One of the clones that had undergone the desired 10 gene replacement (Fig. 1) was selected for further analysis and named ∆glfA. 11
The selected disruptant was further subjected to protoplast transformation with a large DNA 12 fragment encompassing the glfA coding sequence which contained a single translationally silent 13 nucleotide exchange that generated an XhoI restriction site. Gene replacement in the 14 transformants resulted in the reconstitution of the glfA locus ( Fig. 1) as detected by FUDR 15 resistance and proven by Southern Blot analysis for a selected clone named glfA* (Fig. 1B) . The 16 silent mutation introduced in the reconstituted strain allowed differentiating between wild type 17 and glfA* as demonstrated in figure 1B (top) and thus enabled us to rule out contamination by 18 the wt strain. The reconstitution of the glfA locus ensures that any phenotype observed in the 19 ∆glfA strain can be reverted and hence be securely attributed to the loss of the glfA gene. 20 
21
Galf is absent from the A. fumigatus ∆glfA mutant. To confirm that deletion of glfA indeed 22 altered the expression of Galf containing glycoconjugates, aqueous mycelial extracts were tested 23 for reactivity to the Galf-specific monoclonal antibody (mAb) EB-A2. This antibody recognizes 24
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at UNIVERSITEIT GENT/UZGENT on June 18, 2008 ec.asm.org Downloaded from preferably β1,5-linked Galf-residues that are present in all forms of galactomannan (cell-wall 1 bound, membrane bound or secreted) (42) as well as in some O-glycans (23) . Moreover a second 2 binding epitope, Galf(β1,2)Man, which is part of galactofuranosylated N-glycans has been 3 postulated (29) . Thus, EB-A2 can be used to simultaneously detect galactomannan and 4 galactofuranosylated glycoproteins. Western blot analysis of wt and glfA* total mycelial extracts 5 labeled with horseradish peroxidase (HRP) conjugated EB-A2 revealed a smear migrating 6 around 40 to 80 kDa in accordance with previous findings (42) . In contrast, the ∆glfA mycelial 7 extract was not stained at all, indicating absence of Galf in the galactomannan and glycoproteins 8 of this mutant ( Fig. 2A, left) . In contrast, Concanavalin A (ConA) used as loading control bound 9 slightly better to the ∆glfA extract than to those of wt and glfA* ( Fig. 2A, right) . The lack of Galf 10 in the ∆glfA mutant might increase the accessibility of the mannan for ConA and thus could 11 explain this finding. 12
Similarly, the absence of Galf in ∆glfA glycolipids was shown by the absence of reactivity to the 13 monoclonal antibody MEST-1. This antibody that recognizes β1,3-and β1,6-linked Galf residues 14 (43) labeled several A. fumigatus glycosylinositolphosphoceramides (GIPCs) after separation by 15 high-performance thin layer chromatography as previously shown (47) but did not label 16 glycosphingolipids extracted from the ∆glfA mutant (Fig. 2B, left) . The upper bands observed in 17 this panel might be attributed to GIPCs containing 1 or 2 Galf and 2 or 3 mannose residues as 18 recently described (41, 47) . In addition, Simenel et al. reported an unusual GIPC containing a 19
Galf residue substituted by a choline phosphate. The lower band present in the wt chromatogram 20 could correspond to a similar GIPC. Staining of glycolipids by orcinol was used as loading 21 control (Fig. 2B, right) figure 3A (panels 1 and 2) . The peaks labeled 1, 2, 3, 4 and 5 present in both 5 electropherograms co-migrated with reference oligosaccharides M5 to M9 ( Fig. 3A ; panel 9 and 6 Fig. 3B ). Moreover, digestion of these N-glycans by Trichoderma reesei α1,2-mannosidase 7
indicates that 2, 3, 4 and 5 arise from substitution of oligosaccharide 1 with one to four mannose 8 residues linked in α1,2 ( Fig. 3A; panels 3 and 4) . The profile obtained with wt N-glycans (Fig.  9 3A; panel 1) presents four additional peaks labeled 1a, 2a, 3a and 4a that were absent from glfA 10 N-glycans. The retention times of these peaks suggest that they arise from substitution of 11 oligosaccharides 1-4 with a single Galf residue. The presence of a terminal non-reducing Galf 12 residue in A. fumigatus N-glycans has been previously reported (9) and was demonstrated by 13 hydrofluoric acid (HF) treatment of the N-glycans after Trichoderma reesei α1,2-mannosidase 14 digestion (Fig. 3A, panels 5 and 6 ). This mild acid treatment, known to release Galf, entirely 15 converted oligosaccharide 1a into oligosaccharide 1 ( Fig. 3A ; panels 3 and 5). In contrast, HF 16 treatment did not change the profile of ∆glfA N-glycans digested with α1,2 mannosidase (Fig.  17 
3A, panels 4 and 6). 18
Interestingly, the comparison of wt and ∆glfA N-glycans digested with T. reesei α1,2 19 mannosidase or Jack Bean mannosidase helps positioning the Galf residue. Alpha1,2-20 mannosidase treatment converted the oligosaccharides 2a, 3a and 4a into 1a while the 21 oligosaccharides 2, 3 and 4 generated 1 ( Fig. 3A ; compare panels 1 and 2 with 3 and 4). This 22
indicates that the Galf residue does not protect any mannose residues from the exomannosidase 23 digestion and thus does not substitute an α1,2-linked mannose ( Fig. 3A; panels 3 and 4) . 24
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Moreover, Jack Bean mannosidase digestion of wt N-glycans resulted in a major peak (peak 7), 1 attributed to GalfMan 3 GlcNAc 2 from its retention time, in addition to Man 1 GlcNAc 2 (peak 6) 2 expected from digestion of high-mannose type N-glycans ( Fig. 3A ; panels 7 and 8). These 3 experiments do not allow for the determination of the detailed N-glycan structure but suggest 4 that they resemble the N-glycans of A. niger α-glucosidase and α-galactosidase (44, 45) . More 5 importantly, these experiments demonstrate the absence of Galf in the ∆glfA N-glycans. 6 7 Loss of Galf alters morphology and growth of A. fumigatus. The ∆glfA strain exhibited a 8 marked growth defect on solid minimal media or complete media when compared to wt. This 9 effect could be observed for a wide range of temperatures (Fig. 4) and was statistically different 10 in all cases (P < 0.001, t test, n = 3). The most severe effect was found at 42 °C with a 75 % 11 reduction in radial growth (Fig. 4C) . In parallel, ∆glfA conidiation was diminished by 90 % at 37 12 °C and was almost absent at 42 °C. In contrast, the onset and rate of germination of wt, ∆glfA 13 and glfA* conidia were similar. In minimal media at 37 °C, the conidia of all strains started 14 forming germ tubes at 3.2 h and reached 100 % germination within 8 to 9 h (data not shown). 15 Scanning electron micrographs of intact mycelium, conidiophores and conidia of ∆glfA did not 16 reveal any obvious morphologic differences. However, the observation of fractured mycelium 17 revealed a marked reduction of the ∆glfA cell wall thickness ( ∆glfA is more susceptible to drugs. The structural cell wall defect caused by Galf deficiency 1 was accompanied by an increased susceptibility to several antifungal agents (Table 2) . MICs 2 determined in a broth microdilution test were slightly reduced for amphotericin B and 3 caspofungin in the ∆glfA mutant. A more pronounced increase in susceptibility was seen for 4 voriconazole (0.04 mg/L for ∆glfA compared to 0.3 mg/L for wt) and nikkomycin Z (63-125 5 mg/L for ∆glfA and 500 mg/mL for wt), suggesting an increased permeability of the cell wall 6 caused by the loss of Galf. In contrast, the sensitivity towards oxidative stress remained 7 unchanged as indicated by equal MICs for H 2 O 2 in both wt and ∆glfA. influence of the glfA deletion on pathogenicity of A. fumigatus was assessed in a low-dose 11 infection model of invasive aspergillosis (25) . Cyclophosphamide was used to induce 12 neutropenia in female Balb/c mice and a single dose of cortisone acetate was administered before 13 intranasal infection with 20,000 A. fumigatus conidia. Neutropenia was maintained throughout 14 the observation period of 13 days and survival was recorded daily (Fig. 6A) . 90 % of the animals 15 infected with wt did not survive day seven after infection, whereas half of the mice infected with 16 ∆glfA were still alive on day 13. A logrank test on wt and ∆glfA survival data confirmed that the 17 observed difference was statistically significant (P = 0.0004). The attenuation in virulence could 18 clearly be attributed to the absence of glfA, since animals infected with the reconstituted wild 19 type strain glfA* showed a survival pattern nearly identical to wt (no significant difference in 20 logrank test, P = 0.559). Histological examination of lung tissue from mice infected with wt, 21 ∆glfA and glfA* 5 days after inoculation showed evident fungal growth surrounding bronchioles 22 and tissue penetration (Fig. 7) . For each strain, inflammatory cells were rarely observed at the 23 sites of infection. 24
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To correlate the delay in the onset and progression of mortality with a growth defect, fungal 1 burden in lungs of infected mice was determined by quantitative PCR (Fig. 6B ). Mice were 2 treated and infected as described above. After two, four and six days, animals were sacrificed 3 and their lungs taken. DNA was isolated from homogenized lung tissue and fungal content 4 determined by amplification of a part of A. fumigatus ribosomal DNA. As shown in figure 6B , 5 growth of ∆glfA was restricted in vivo when compared to wt, which was in agreement with the 6 slower growth observed in vitro. 7 trimming of high mannose glycans has been shown previously (52, 13) . Interestingly, Galf 1 addition has been suggested to act as a stop signal for mannose addition in analogy to the role 2 proposed for α1,3-linked terminal mannose in Saccharyomyces cerevisiae (29, 49) . However, 3 preventing the addition of galactofuranose does not result in an increased size of the 4 oligosaccharides. On the contrary, Man 5 GlcNAc 2 is the main oligosaccharide found in the ∆glfA 5 mutant while GalfMan 6 GlcNAc 2 is predominant in wild type. 6
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Although glfA deletion has been shown to be lethal in Mycobacterium smegmatis (32) , the in 7 vitro viability of A. fumigatus ∆glfA mutant is unsurprising since Galf occupies a non-reducing 8 terminal position in the molecules of this fungus. Hence, the absence of Galf does not perturb the 9 basic organization of the cell wall, as would the absence of the underlying structures. 10
Nevertheless, it resulted in marked alterations of the cell surface and notably a thinner cell wall 11 as revealed by electron microscopy. The basis of this drastic change is unclear and difficult to 12 attribute to a particular cell wall component since GPI-/cell wall bound galactomannan, N-13 glycans, O-glycans and GIPCs are affected by Galf deficiency. In other fungi, the loss of 14 terminal sugar residues has sometimes been associated with reduced cell wall strength. For 15 instance, a Schizosaccharomyces pombe mutant deficient in cell wall galactosylation displays 16 morphological changes, attenuated growth and a 25-35 % reduction in cell wall thickness (46) . 17
The structural changes originating from the glfA deletion are associated with slower growth 18 indicating that Galf plays an important role in A. fumigatus morphogenesis. The temperature-19 sensitive growth defect at higher temperature displayed by the ∆glfA mutant is reminiscent to 20 that observed in the ∆AfPmt1 mutant, a mutant characterized by reduced O-glycosylation (53) . 21 Interestingly, an influence of Galf deficiency on the growth rate was also observed in ∆glfA 22 mutants of Aspergillus nidulans and Aspergillus niger (10) . Conversely glfA deletion had no 23
at UNIVERSITEIT GENT/UZGENT on June 18, 2008 ec.asm.org Downloaded from effect on the in vitro growth of Leishmania parasites (16) highlighting that the role of Galf 1 cannot be translated to every Galf containing organism. 2
The ability to thrive at 37 °C is a characteristic of human pathogens that has been shown to 3 correlate with virulence potential in the case of A. fumigatus (31) . Consequently, mutations that 4 affect the growth of fungi at mammalian body temperature are commonly associated with 5 attenuated virulence (40) . In this study, we observed slower growth of the A. fumigatus ∆glfA 6 mutant in vitro but also in vivo using quantitative PCR. In agreement with this observation, the 7 mutant was clearly attenuated in virulence showing a delay in both the onset and progression of 8 mortality when tested in a low dose mouse infection model of invasive aspergillosis. An altered 9 immune response caused by the different cell wall structure of the ∆glfA mutant may also 10 contribute to the attenuation in virulence. However, no differences in adherence and uptake of wt 11 and ∆glfA conidia by murine bone-marrow derived dendritic cells or in the production of TNF-α 12 or IL-10 by infected murine bone-marrow derived macrophages were observed (K. Kotz, F. Ebel 13 and F.H. Routier, unpublished data). 14 The value of echinocandins in invasive aspergillosis treatment resides in their synergistic effects 15 with azoles and amphotericin B. Similarly, chitin synthesis inhibitors demonstrate synergy with 16 echinocandins and azoles (24) . These synergistic effects that offer new options for combination 17 antifungal therapy are most likely due to greater cell wall permeability. We did note an increase 18 in susceptibility of the ∆glfA mutant to several antifungal agents, notably to voriconazole. 
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